title: FDA notifications.  FDA approves new atazanavir labeling.
mesh_terms: D000069446:Atazanavir Sulfate; D000075202:Contraindications; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004347:Drug Interactions; D005260:Female; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009842:Oligopeptides / Q000009:adverse effects / Q000627:therapeutic use*; D011247:Pregnancy; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate